Atlanta, June 2007 – The fifth-largest biopharmaceutical company in the world, Belgium-based UCB Pharma S.A., announced the $5 million USD expansion at it’s Smyrna, Georgia, subsidiary. Active in Georgia since 1995, the company currently employs about 650 employees. The expansion is expected to add another 100 high-level jobs.
“Atlanta, home of the U.S. headquarters of UCB, is our gateway to the North American market and one of our strategic sites. We are extremely pleased that the state of Georgia supports UCB on our road to building the next generation biopharma leader,” stated Roch Doliveux, Chief Executive Officer of UCB.